MAX Automation SE

  • WKN: A2DA58
  • ISIN: DE000A2DA588
  • Land: Deutschland

Nachricht vom 19.09.2019 | 17:53

MAX Automation SE: Supervisory Board decides to terminate investment agreement with joint venture partner Roger Liujie in China

MAX Automation SE / Key word(s): Strategic Company Decision
MAX Automation SE: Supervisory Board decides to terminate investment agreement with joint venture partner Roger Liujie in China

19-Sep-2019 / 17:53 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


AD HOC RELEASE (PURSUANT TO SECTION 17 GERMAN SECURITIES TRADING ACT (WPHG))

MAX Automation SE: Supervisory Board decides to terminate investment agreement with joint venture partner Roger Liujie in China

Dusseldorf, 19 September 2019 - The Supervisory Board of MAX Automation SE has decided to terminate the investment agreement with joint venture partner Roger Liujie in China. Furthermore, the Supervisory Board is considering to take legal action against Roger Liujie up to the extent of a complete reversal of the transaction based on the investment agreement dated February 2018. As a result, the acquisition of the majority stake in the Chinese engineering company Shanghai Cisens Automation Co, Ltd. would be retransferred. In February 2018, the business operations of Shanghai Cisens Automation Co., Ltd. were transferred in the form of an asset deal to a new company, MAX Automation (Shanghai) Co., Ltd., in which the MAX Group holds 51% and the founder and CEO Roger Li Liujie holds 49% of the shares.

Contact:
Katja Redweik
Head of Corporate Development/IR
MAX Automation SE
Tel.: +49 - 211 - 9099 144
katja.redweik@maxautomation.com
www.maxautomation.com

Contact for media representatives:

Susan Hoffmeister   Marco Cabras
CROSS ALLIANCE communication GmbH   newskontor - Agentur für Kommunikation
Tel.: +49 - 89 - 125 09 03 30   Tel.: +49 - 211 - 863 949 22
sh@crossalliance.de   marco.cabras@newskontor.de

19-Sep-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Wirecard AG beauftragt unabhängige Prüfung

21. Oktober 2019, 07:40

Aktuelle Research-Studie

ad pepper media International N.V.

Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Hinzufügen

18. Oktober 2019